These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33259228)

  • 81. Homogeneous proximity tyrosine kinase assays: scintillation proximity assay versus homogeneous time-resolved fluorescence.
    Park YW; Cummings RT; Wu L; Zheng S; Cameron PM; Woods A; Zaller DM; Marcy AI; Hermes JD
    Anal Biochem; 1999 Apr; 269(1):94-104. PubMed ID: 10094779
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Heterogeneous and homogeneous immunoassays for drug analysis.
    Dinis-Oliveira RJ
    Bioanalysis; 2014; 6(21):2877-96. PubMed ID: 25486233
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hazards in chromatographic bioanalysis method development and applications.
    Hooshfar S; Bartlett MG
    Biomed Chromatogr; 2017 Jan; 31(1):. PubMed ID: 27696464
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Highly sensitive homogenous chemiluminescence immunoassay using gold nanoparticles as label.
    Luo J; Cui X; Liu W; Li B
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Oct; 131():243-8. PubMed ID: 24835732
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Multiple homogeneous immunoassays based on a quantum dots-gold nanorods FRET nanoplatform.
    Zeng Q; Zhang Y; Liu X; Tu L; Kong X; Zhang H
    Chem Commun (Camb); 2012 Feb; 48(12):1781-3. PubMed ID: 22218498
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Active glucagon-like peptide 1 quantitation in human plasma: a comparison of multiple ligand binding assay platforms.
    Fraser S; Dysinger M; Soderstrom C; Kuhn M; Durham R
    J Immunol Methods; 2014 May; 407():76-81. PubMed ID: 24721392
    [TBL] [Abstract][Full Text] [Related]  

  • 87. A universal homogeneous assay for high-throughput determination of binding kinetics.
    Schiele F; Ayaz P; Fernández-Montalván A
    Anal Biochem; 2015 Jan; 468():42-9. PubMed ID: 25240173
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Influence of luminescence quantum yield, surface coating, and functionalization of quantum dots on the sensitivity of time-resolved FRET bioassays.
    Wegner KD; Lanh PT; Jennings T; Oh E; Jain V; Fairclough SM; Smith JM; Giovanelli E; Lequeux N; Pons T; Hildebrandt N
    ACS Appl Mater Interfaces; 2013 Apr; 5(8):2881-92. PubMed ID: 23496235
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Particulate and soluble Eu(III)-chelates as donor labels in homogeneous fluorescence resonance energy transfer based immunoassay.
    Kokko L; Kokko T; Lövgren T; Soukka T
    Anal Chim Acta; 2008 Jan; 606(1):72-9. PubMed ID: 18068773
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Addressing matrix effects in ligand-binding assays through the use of new reagents and technology.
    Chilewski SD; Mora JR; Gleason C; DeSilva B
    Bioanalysis; 2014 Apr; 6(8):1059-67. PubMed ID: 24830890
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A decade of development in immunoassay methodology.
    Gosling JP
    Clin Chem; 1990 Aug; 36(8 Pt 1):1408-27. PubMed ID: 2201458
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Evaluation of assay technologies for the identification of protein-Peptide interaction antagonists.
    Kadkhodayan S; Elliott LO; Mausisa G; Wallweber HA; Deshayes K; Feng B; Fairbrother WJ
    Assay Drug Dev Technol; 2007 Aug; 5(4):501-13. PubMed ID: 17767418
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood.
    Lundberg M; Eriksson A; Tran B; Assarsson E; Fredriksson S
    Nucleic Acids Res; 2011 Aug; 39(15):e102. PubMed ID: 21646338
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Assay formats: Recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team.
    Dudal S; Baltrukonis D; Crisino R; Goyal MJ; Joyce A; Osterlund K; Smeraglia J; Taniguchi Y; Yang J
    AAPS J; 2014 Mar; 16(2):194-205. PubMed ID: 24343771
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Immunoassay Methods and their Applications in Pharmaceutical Analysis: Basic Methodology and Recent Advances.
    Darwish IA
    Int J Biomed Sci; 2006 Sep; 2(3):217-35. PubMed ID: 23674985
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The bioanalytical tools that support cell and gene therapy development.
    Maundrell N
    Bioanalysis; 2021 Oct; 13(20):1529-1531. PubMed ID: 34617448
    [No Abstract]   [Full Text] [Related]  

  • 97. Induced protein proximity drug discovery, from 30,000 feet.
    Mullard A
    Nat Rev Drug Discov; 2022 Mar; 21(3):172-173. PubMed ID: 35177835
    [No Abstract]   [Full Text] [Related]  

  • 98. Recent advances in homogeneous and separation-free enzyme immunoassays.
    Ngo TT; Lenhoff HM
    Appl Biochem Biotechnol; 1981 Mar; 6(1):53-64. PubMed ID: 24233657
    [No Abstract]   [Full Text] [Related]  

  • 99. Evaluation of homogeneous proximity immunoassays for preclinical bioanalysis.
    Eangoor P; Das S; Pucci V
    Bioanalysis; 2020 Dec; 12(24):1757-1766. PubMed ID: 33259228
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis.
    Roman J; Qiu J; Dornadula G; Hamuro L; Bakhtiar R; Verch T
    J Pharmacol Toxicol Methods; 2011; 63(3):227-35. PubMed ID: 21147239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.